Antimicrobials
CefTAZidime

CefTAZidime

High
N/A

Dosing

General Information

Treatment or empiric therapy for presumed Pseudomonas infections

Poor activity for most Gram-positive microorganisms

Does not treat ESBL producing microorganisms

Allergy (immediate and delayed). Neurotoxicity (if not dose adjusted in renal failure) Note potential cross-reactivity with aztreonam based on side chain.

Antimicrobial class: 3rd generation Cephalosporin

Pregnancy category: B

Average serum half life: 2 hours

Urine penetration: Therapeutic

Lung penetration: Therapeutic

CSF penetration: Therapeutic

Biliary penetration: Moderate